Innovative Approaches to Developing Broad-spectrum Antibodies and Therapeutics

The chapter delves into the challenges of creating cross-reactive antibodies against multiple pathogens and adapting to new variants. It emphasizes leveraging data and machine learning to predict antibody sequences and optimize protein therapeutics for diseases like HIV. The discussion also focuses on Alphabio's partnerships with pharmaceutical companies and their innovative approaches to identifying molecular glue for drug discovery.